High expression of CDK6 confers resistance to fulvestrant in breast cancer cells and is a potential predictor of fulvestrant treatment failure in estrogen receptor-positive breast cancer

Carla Maria Lourenco Alves, Daniel Elias, Maria Bibi Lyng, Martin Bak, Anne Elisabeth Lykkesfeldt, Henrik Ditzel

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

96 Downloads (Pure)
Original languageEnglish
Publication date7. Feb 2015
Publication statusPublished - 7. Feb 2015
EventAACR Meeting Translation of the Cancer Genome - San Francisco, United States
Duration: 7. Feb 20159. Feb 2015

Conference

ConferenceAACR Meeting Translation of the Cancer Genome
CountryUnited States
CitySan Francisco
Period07/02/201509/02/2015

Cite this